Currency in USD
Earnings estimate | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
---|
No. of analysts | 1 | 1 | 4 | 4 |
Avg. Estimate | 0.96 | 1.26 | 3.99 | 4.52 |
Low estimate | 0.96 | 1.26 | 3.96 | 4.4 |
High estimate | 0.96 | 1.26 | 4.01 | 4.58 |
Year ago EPS | 0.97 | 1.28 | 3.86 | 3.99 |
Revenue estimate | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
---|
No. of analysts | 2 | 2 | 6 | 6 |
Avg. Estimate | 9.43B | 10.79B | 39.73B | 42.33B |
Low estimate | 9.37B | 10.73B | 39.49B | 41.63B |
High estimate | 9.49B | 10.85B | 39.96B | 43.09B |
Year ago sales | 8.99B | 9.44B | 37.7B | 39.73B |
Sales growth (year/est) | 4.90% | 14.20% | 5.40% | 6.50% |
Earnings history | 29/06/2023 | 29/09/2023 | 30/12/2023 | 30/03/2024 |
---|
Est. EPS | 0.87 | 1.14 | 0.76 | 0.91 |
Actual EPS | 0.97 | 1.28 | 0.72 | 1.09 |
Difference | 0.1 | 0.14 | -0.04 | 0.18 |
Surprise % | 11.50% | 12.30% | -5.30% | 19.80% |
EPS trend | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
---|
Current estimate | 0.96 | 1.26 | 3.99 | 4.52 |
7 days ago | 0.94 | 1.28 | 3.96 | 4.49 |
30 days ago | 0 | 0 | 4.02 | 4.54 |
60 days ago | 0 | 0 | 3.99 | 4.45 |
90 days ago | 0 | 0 | 4.05 | 4.49 |
EPS revisions | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
---|
Up last 7 days | 1 | N/A | 1 | 1 |
Up last 30 days | 1 | N/A | 2 | 2 |
Down last 7 days | N/A | N/A | N/A | N/A |
Down last 30 days | N/A | 1 | N/A | N/A |
Growth estimates | GSK | Industry | Sector(s) | S&P 500 |
---|
Current qtr. | -1.00% | N/A | N/A | N/A |
Next qtr. | -1.60% | N/A | N/A | N/A |
Current year | 3.40% | N/A | N/A | N/A |
Next year | 13.30% | N/A | N/A | N/A |
Next 5 years (per annum) | 4.80% | N/A | N/A | N/A |
Past 5 years (per annum) | -0.77% | N/A | N/A | N/A |